siRNA treatment reduces triglycerides in clients with uncommon health condition

.INVESTIGATION EMPHASIZE.19 September 2024.

Plozasiran minimized triglyceride degrees through 80% as well as reduced the risk of pancreatitis in clients along with chronic chylomicronemia, with or without a genetic diagnosis.